Abstract

The Absolute Volume of PET-Defined, Active Bone Marrow Spared Predicts for High Grade Hematologic Toxicity in Cervical Cancer Patients Undergoing Chemoradiation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Use of 18FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation Therapy
O Elicin ... M Ozsahin
International Journal of Radiation Oncology, Biology, Physics | VOL. 87
O Elicin, et. al.O Elicin ... M Ozsahin
20 Sep 2013
The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation.
Y M Zhou ... T Meier
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. 20
Y M Zhou, et. al.Y M Zhou ... T Meier
26 Oct 2017
18F]FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation Therapy
Olgun Elicin ... Fernanda G Herrera
International Journal of Radiation Oncology, Biology, Physics | VOL. 90
Olgun Elicin, et. al.Olgun Elicin ... Fernanda G Herrera
13 Oct 2014
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy
Loren K Mell ... Joel D Kochanski
International Journal of Radiation Oncology, Biology, Physics | VOL. 66
Loren K Mell, et. al.Loren K Mell ... Joel D Kochanski
06 Jun 2006
View more papers

More From: International Journal of Radiation Oncology, Biology, Physics

Paper Title
Journal
Date
Author
Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial
Diego A S Toesca ... Carlos E Vargas
International Journal of Radiation Oncology, Biology, Physics | VOL. -
Diego A S Toesca, et. al.Diego A S Toesca ... Carlos E Vargas
05 Jul 2024
PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy
Jan Hrbacek ... Kavita K Mishra
International Journal of Radiation Oncology, Biology, Physics | VOL. -
Jan Hrbacek, et. al.Jan Hrbacek ... Kavita K Mishra
04 Jul 2024
Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT): Analysis of Toxicity and Quality of Life from a Prospective Study
Stefano Arcangeli ... Denis Panizza
International Journal of Radiation Oncology, Biology, Physics | VOL. -
Stefano Arcangeli, et. al.Stefano Arcangeli ... Denis Panizza
04 Jul 2024
Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer
Donna M Edwards ... Shruti Jolly
International Journal of Radiation Oncology, Biology, Physics | VOL. -
Donna M Edwards, et. al.Donna M Edwards ... Shruti Jolly
04 Jul 2024
View more papers